Ultragenyx Pharmaceutical Inc.
RARE
$29.65
-$0.66-2.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.39% | -18.95% | 0.41% | -20.46% | 85.36% |
| Total Receivables | 23.85% | -16.80% | 29.97% | -12.17% | 7.79% |
| Inventory | 1.01% | 2.28% | 3.86% | 7.97% | 11.78% |
| Prepaid Expenses | 4.09% | 49.50% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.58% | 24.55% | -87.32% | 2.41% | 10.25% |
| Total Current Assets | 2.95% | -14.44% | 2.19% | -17.11% | 61.86% |
|
|
|||||
| Total Current Assets | 2.95% | -14.44% | 2.19% | -17.11% | 61.86% |
| Net Property, Plant & Equipment | -1.97% | -10.47% | 6.97% | -2.25% | -2.25% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.01% | -1.00% | 8.11% | -0.78% | 0.73% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.61% | 67.76% | -30.99% | 0.19% | -10.34% |
| Total Assets | -0.43% | -12.74% | -2.27% | -4.95% | 23.82% |
|
|
|||||
| Total Accounts Payable | -27.84% | 22.43% | 7.69% | -39.82% | 45.97% |
| Total Accrued Expenses | 4.50% | -28.20% | 30.24% | 19.82% | 3.55% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.44% | 12.83% | 1.67% | 0.88% | 5.71% |
| Total Finance Division Other Current Liabilities | -22.91% | -21.78% | -11.48% | -- | -- |
| Total Other Current Liabilities | -22.91% | -21.78% | -11.48% | -- | -- |
| Total Current Liabilities | 0.54% | -15.25% | 20.75% | 4.45% | 11.11% |
|
|
|||||
| Total Current Liabilities | 0.54% | -15.25% | 20.75% | 4.45% | 11.11% |
| Long-Term Debt | -1.42% | -3.14% | -1.19% | -1.48% | -0.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.71% | -7.51% | 26.99% | -8.10% | -8.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.58% | 0.09% | 2.07% | 2.06% | 1.61% |
| Total Liabilities | -1.09% | -6.48% | 4.78% | -0.13% | 1.65% |
|
|
|||||
| Common Stock & APIC | 2.87% | 0.94% | 1.04% | 1.11% | 11.47% |
| Retained Earnings | -2.80% | -3.82% | -3.49% | -3.62% | -3.70% |
| Treasury Stock & Other | 21.41% | 46.97% | -171.76% | 181.83% | -154.06% |
| Total Common Equity | 4.88% | -43.50% | -26.39% | -19.79% | 208.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.88% | -43.50% | -26.39% | -19.79% | 208.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Equity | 4.65% | -42.34% | -25.87% | -18.17% | 208.29% |
|
|
|||||